- Latest Updates
FDA authorizes Pfizer’s vaccine for emergency use in kids ages 5 to 11
The U.S. is prepared to roll out doses to kids as soon as the CDC gives its final approval, which is expected to come early next week.
What you need to know:
● COVID-19 has killed nearly 5 million people—and the pandemic is far from over
● What to expect with COVID-19 vaccines for kids ages 5 to 11
● Why even fully vaccinated older people are at high risk for severe COVID-19
● How to confront the pandemic's toll on kids’ mental health
The U.S. Food and Drug Administration has granted emergency use authorization to Pfizer’s low dose COVID-19 vaccine for kids ages five to 11. The FDA’s announcement is a critical step in the process to begin rolling out the shots.
“Vaccinating younger children against COVID-19 will bring us closer to returning to a sense of normalcy,” acting FDA commissioner Janet Woodcock said in the announcement. “Our comprehensive and rigorous evaluation of the data pertaining to the vaccine’s safety and effectiveness should help assure parents and guardians that this vaccine meets our high standards.”
Next, the U.S. Centers for Disease Control and Prevention will weigh in on who should receive the vaccine during a meeting scheduled for next week. Once the CDC